Filing Details
- Accession Number:
- 0001140361-12-005402
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-03 17:50:24
- Reporting Period:
- 2012-02-01
- Filing Date:
- 2012-02-03
- Accepted Time:
- 2012-02-03 17:50:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1379246 | Body Central Corp | BODY | Retail-Apparel & Accessory Stores (5600) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1503259 | Scott Gallin | C/O Pinebridge Investments Llc 399 Park Avenue, 4Th Floor New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-02-01 | 111,393 | $26.30 | 342,883 | No | 4 | S | Indirect | See Footnote 3 |
Common Stock | Disposition | 2012-02-02 | 10,791 | $26.24 | 332,092 | No | 4 | S | Indirect | See Footnote 3 |
Common Stock | Disposition | 2012-02-02 | 37,948 | $25.62 | 294,144 | No | 4 | S | Indirect | See Footnote 3 |
Common Stock | Disposition | 2012-02-02 | 2,900 | $24.90 | 291,244 | No | 4 | S | Indirect | See Footnote 3 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote 3 |
No | 4 | S | Indirect | See Footnote 3 |
No | 4 | S | Indirect | See Footnote 3 |
No | 4 | S | Indirect | See Footnote 3 |
Footnotes
- The reported sales were made pursuant to Rule 10b5-1 trading plans.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.06 to $26.87, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Each of PineBridge PEP III Direct, L.P., PineBridge PEP IV Co-Investment, L.P., PineBridge Vantage Partners, L.P. and American International Group, Inc. Retirement Plan Master Trust is the record holder of 5,615, 44,914, 227,928 and 12,787 shares of common stock of the issuer, respectively, after the reported transactions and is advised by PineBridge Investments LLC ("PineBridge Investments"). PineBridge Investments has sole voting power and sole investment power over these shares and is the beneficial owner of the shares held by these entities. Scott Gallin is a managing director of PineBridge Investments and may be deemed to beneficially own the shares of common stock held by these entities. Mr. Gallin disclaims such beneficial ownership. Each of the above entities holding these shares as a record holder disclaims beneficial ownership of the securities held of record by the other entities.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.41, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.99, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.88 to $24.99, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.